Allianz Asset Management
ALBO

Allianz Asset Management’s Albireo Pharma Inc ALBO Stock Holding History

Allianz Asset Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-16,052
Closed -$321K – 2881
2019
Q3 		$321K Sell
16,052
-23,304
-59% -$603K ﹤0.01% 2506
2019
Q2 		$1.27M Buy
39,356
+2,908
+8% +$97.3K ﹤0.01% 2061
2019
Q1 		$1.17M Sell
36,448
-570
-2% -$15.3K ﹤0.01% 2035
2018
Q4 		$908K Sell
37,018
-1,471
-4% -$38.9K ﹤0.01% 2069
2018
Q3 		$1.27M Buy
38,489
+3,275
+9% +$107K ﹤0.01% 2125
2018
Q2 		$1.25M Buy
+35,214
New +$1.14M ﹤0.01% 2142

Other funds holding ALBO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Allianz Asset Management's ALBO Position: Q4 2019 in Review

Allianz Asset Management sold out of Albireo Pharma Inc (ALBO) in Q4 2019, closing a stake of 16,052 shares — an estimated $321K sold.

Allianz Asset Management first reported a position in ALBO in Q2 2018 and held it in 6 quarters. The position peaked at $1.27M in Q2 2019. 70 funds tracked by Wall St. Rank hold ALBO as of Q4 2019.

  • Allianz Asset Management reported no remaining Albireo Pharma Inc position as of Q4 2019 after selling out during the quarter.
  • Allianz Asset Management sold 16,052 Albireo Pharma Inc shares in Q4 2019, an estimated $321K.
  • Allianz Asset Management first reported a position in Albireo Pharma Inc in Q2 2018 and held it in 6 quarters.
  • Allianz Asset Management's Albireo Pharma Inc position peaked at $1.27M in Q2 2019.
  • 70 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2019.

Based on Allianz Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.